سعر كات داون 120 مجم 20 كبسولة 2022

Cut down 120 mg capsules, 20 caps: orlistat (Sabaa > Novell Pharma). Gastrointestinal lipase inhibitor for obesity management.

• Obesity management including weight loss and weight maintenance with a reduced-calorie diet; also to reduce risk of weight regain after prior weight loss. Indicated for BMI ≥30 kg/m² or ≥27 kg/m² with risk factors (US XENICAL).Population: Adults (and adolescents 12–16 years as labeled in US)DailyMed (NLM)

• Most common (≥5% and ≥2× placebo): oily spotting, flatus with discharge, fecal urgency, fatty/oily stool, oily evacuation, increased defecation, fecal incontinence.International label, same formulation · DailyMed (NLM)

• Contraindicated in pregnancy; chronic malabsorption syndrome; cholestasis; known hypersensitivity to orlistat or any component.International label, same formulation · DailyMed (NLM)

• Decreases absorption of some fat-soluble vitamins — take daily multivitamin. Rare severe liver injury reported. May increase urinary oxalate (nephrolithiasis/nephropathy risk). Substantial weight loss increases cholelithiasis risk. GI events increase with high-fat meals.International label, same formulation · DailyMed (NLM)

• CyclosporineMajorReduces cyclosporine levels; separate administration (cyclosporine 3 hours after orlistat) and monitor levels.DailyMed (NLM)
• LevothyroxineModerateAdminister at least 4 hours apart; monitor thyroid function.DailyMed (NLM)
• Warfarin / anticoagulantsModerateVitamin K absorption may decrease; monitor coagulation parameters.DailyMed (NLM)

• US label Pregnancy Category X — contraindicated in pregnancy; weight loss offers no benefit and may harm the fetus.International label, same formulation · DailyMed (NLM)
• Unknown whether present in human milk; caution when administered to a nursing woman (US XENICAL).International label, same formulation · DailyMed (NLM)

• Orlistat: Inhibits gastric and pancreatic lipases, reducing dietary triglyceride hydrolysis and fat absorption.